by Nassir Ghaemi | Aug 27, 2025
Is adult ADD a myth? Dr. Nasiragami breaks down why inattention isn’t a distinct disorder and warns about amphetamine risks. In this livestream Dr. Nasiragami argues that the condition should be called ADD, dropping the “H” because hyperactivity has never...
by Nassir Ghaemi | Aug 27, 2025
Ever wondered why the chemistry behind psych meds often misleads clinicians? We break down why drug mechanisms usually don’t drive treatment decisions. In this live episode Dr. Nasir Gammi welcomes resident Daniel Herringer to argue that most psychopharmacology drugs...
by Nassir Ghaemi | Aug 27, 2025
Are we mislabeling mental‑health “comorbidities” and over‑medicating patients? In this live‑stream episode, host Nasiragami sits down with psychiatry resident Daniel Herringer to challenge the way DSM defines comorbid disorders. They trace the origin of the term from...
by Nassir Ghaemi | Aug 16, 2025
A psychiatrist pulls back the curtain on psychedelics, exposing hype, weak data, and hidden conflicts of interest. Dr. Daniel Heringer, a psychiatry resident in Cleveland, sits down with mentor Dr. Nassir Ghaemi to clarify terminology—why “hallucinogen” is the...
by Nassir Ghaemi | Aug 16, 2025
What really counts as trauma? Dr. Nassir Ghaemi untangles PTSD, combat, sexual abuse and the myth of “complex trauma”. In this live‑stream episode Dr. Ghaemi explains why the word “trauma” should be reserved for truly extreme events—historically rooted in Freud’s...
